CD79A and triple-A syndrome: Similarly, previous studies have tested IgA antibodies against Chlamydia pneumoniae [47] or malondialdehyde-acetaldehyde [48] in AAA plasmas, demonstrating their potential as circulating biomarkers of AAA.